Sonoma Pharmaceuticals
SNOA
13 hedge funds and large institutions have $456K invested in Sonoma Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% less ownership
Funds ownership: 0.3% → 0.3% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
28% less capital invested
Capital invested by funds: $631K → $456K (-$175K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$47.6K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$1.42K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$129 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LWM
Liberty Wealth Management
Oakland,
California
|
-$33K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$16K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $268K | +$47.6K | +369 | +19% |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $142K | -$16K | -124 | -9% |
|
3
BlackRock
New York
| $20K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | -$10.3K | -80 | -40% |
|
5
Acadian Asset Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
7
Morgan Stanley
New York
| $1K | – | – | – |
|
|
8
Victory Capital Management
San Antonio,
Texas
| $1K | +$1.42K | +11 | New |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $12 | – | – | – |
|
|
LWM
10
Liberty Wealth Management
Oakland,
California
| – | -$33K | -209 | Closed |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | +$129 | +1 | +33% |
|
|
SFS
12
Sowell Financial Services
North Little Rock,
Arkansas
| – | +$129 | +1 | New |
|
SNOA Hedge Fund Activity: Q3 2019 in Review
13 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2019, worth a combined $456K — down 28% from $631K a quarter earlier.
Fund positioning in SNOA was balanced in Q3 2019: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $47.6K. The largest seller was Liberty Wealth Management, exiting entirely with an estimated $33K sold.
- 13 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $456K of Sonoma Pharmaceuticals stock for Q3 2019, down 28% quarter-over-quarter.
- 2 funds opened new Sonoma Pharmaceuticals positions in Q3 2019 and 2 closed out, a net change of 0 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2019 was Renaissance Technologies, an estimated $47.6K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2019 was Liberty Wealth Management, an estimated $33K sold.
Based on aggregated 13F filings for Q3 2019.